Skip to main content
Premium Trial:

Request an Annual Quote

BGI to Offer Noninvasive Trisomy Test in Czech, Slovak Republics

NEW YORK (GenomeWeb News) – BGI has partnered with GENNET, a Prague-based center for genetics, fetal medicine, and assisted reproduction, to offer its non-invasive fetal trisomy test, NIFTY, in the Czech and Slovak Republics.

The NIFTY test uses next-generation sequencing to analyze maternal plasma for fetal aneuploidies including trisomy 21, trisomy 13, and trisomy 18, which cause Down syndrome, Patau syndrome, and Edwards syndrome, respectively.

BGI will provide the sequencing and bioinformatics analysis for the test, while GENNET will serve as the distribution network.

"GENNET's long experience in fetal medicine makes it a natural choice for us to cooperate here in Czech Republic," Ning Li, the director of BGI Europe, said in a statement. "We are looking forward to having more collaboration together on medical genomics and medical diagnostics in the near future."